New GRAPPA and EULAR recommendations for the management of psoriatic arthritis by Coates, L, Gossec, L, Ramiro, S, Mease, P, Van Der Heijde, D, Smolen, J, Ritchlin, C, Kavanaugh, A

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. by Elliott, M, Maini, R, Feldmann, M, Kalden, JR, Antoni, C, Smolen, J, Leeb, B, Breedveld, F, Macfarlane, J, Bijl, H

GOLIMUMAB IS EFFICACIOUS IN ANTI-TNF EXPERIENCED PTS WITH ACTIVE RA REGARDLESS OF TYPE OF AGENT OR REASON FOR DISCONTINUATION OF PRIOR ANTI-TNF: GO-AFTER STUDY by Smolen, J, Wordsworth, P, Doyle, M, Kay, J, Matteson, E, Landewe, R, Hsia, E, Zhou, Y, Rahman, M, Investigator, G

GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY) by Wordsworth, P, Smolen, J, Kay, J, Doyle, M, Landewe, R, Matteson, E, Zhou, Y, Hsia, E, Rahman, M, Investigators, GO-AFTERS

Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis by Taylor, P, Takeuchi, T, Burmester, G, Durez, P, Smolen, J, Deberdt, W, Zhong, J, Teres, JR, Bello, N, Winthrop, K, Pope, J

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete respon... by Maini, R, Taylor, P, Szechinski, J, Pavelka, K, Bröll, J, Balint, G, Emery, P, Raemen, F, Petersen, J, Smolen, J, Thomson, D, Kishimoto, T

Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete respon... by Maini, R, Taylor, P, Szechinski, J, Pavelka, K, Broll, J, Balint, G, Emery, P, Raemen, F, Petersen, J, Smolen, J, Thomson, D, Kishimoto, T

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. by Maini, R, Breedveld, F, Kalden, JR, Smolen, J, Davis, D, Macfarlane, J, Antoni, C, Leeb, B, Elliott, M, Woody, J, Schaible, T, Feldmann, M

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase I... by Maini, R, St Clair, E, Breedveld, F, Furst, D, Kalden, J, Weisman, M, Smolen, J, Emery, P, Harriman, G, Feldmann, M, Lipsky, P

GOLIMUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION AND FATIGUE IN RA PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF AGENTS: RESULTS FROM THE GO-AFTER STUDY by Kay, J, Wordsworth, P, Doyle, M, Smolen, J, Buchanan, J, Matteson, E, Hsia, E, Landewe, R, Zhou, Y, Shreekant, P, Rahman, M, Investigators, GO-AFTER

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. by Charles, P, Elliott, M, Davis, D, Potter, A, Kalden, JR, Antoni, C, Breedveld, F, Smolen, J, Eberl, G, deWoody, K, Feldmann, M, Maini, R

Infliximab and methotrexate in the treatment of rheumatoid arthritis by Lipsky, P, Van Der Heijde, D, St Clair, E, Furst, D, Breedveld, F, Kalden, JR, Smolen, J, Weisman, M, Emery, P, Feldmann, M, Harriman, G, Maini, R

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. by Lipsky, P, van der Heijde, D, St Clair, E, Furst, D, Breedveld, F, Kalden, JR, Smolen, J, Weisman, M, Emery, P, Feldmann, M, Harriman, G, Maini, R

Perceptions of risk and predictive testing held by the first-degree relatives of patients with rheumatoid arthritis in England, Austria and Germany: a qualitative study by Stack, RJ, Stoffer, M, Englbrecht, M, Mosor, E, Falahee, M, Simons, G, Smolen, J, Schett, G, Buckley, CD, Kumar, K, Hansson, M, Hueber, A, Stamm, T, Raza, K

Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis by Emery, P, Dudler, J, Smolen, J, Zerbini, C, Burmester, G, Fautrel, B, Van Der Laar, M, Fleischmann, R, Fakhouri, W, De Leonardis, F, Zhu, B, Kadziola, Z, De La Torre, I, Perrier, C, Taylor, P

Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000). by Furst, D, Breedveld, F, Burmester, G, Crofford, J, Emery, P, Feldmann, M, Kalden, JR, Kavanaugh, A, Keystone, E, Klareskog, L, Lipsky, P, Maini, R, Russell, A, Scott, D, Smolen, J, Van de Putte, L, Visher, T, Weisman, M

Treat-to-target in rheumatoid arthritis: Clinical and pharmacoeconomic considerations by Beresniak, A, Braun, J, Cortesi, P, Ferraccioli, G, Hetland, M, Jacobs, J, Kavanaugh, A, Luqmani, R, Mosca, M, Pincus, T, Porter, D, Rantalaiho, V, Ravelli, A, Scott, D, Smolen, J, Thielscher, C, Turchetti, G, Van Den Broek, M, Yazici, Y

Eular evidence based recommendations for the diagnosis of hand osteoarthritis - Report of a task force of the EULAR standing committe for International Clinical Studies Including T... by Zhang, W, Doherty, M, Leeb, B, Alekseeva, L, Arden, N, Bijisma, J, Dincer, F, Dziedzic, K, Hauselmann, H, Kaklamanis, P, Kloppenburg, M, Lohmander, S, Maheu, E, Martin-Mola, E, Pavelka, K, Punzi, L, Reiter, S, Smolen, J, Verbruggen, G, Watt, I, Zimmermann-Gorska, I

Eular evidence based recommendations for the management of hand osteoarthritis - Report of a task force of the eular standing committe for international clinical studies including... by Zhang, W, Doherty, M, Leeb, B, Arden, N, Bijlsma, J, Dincer, F, Dziedzic, K, Hauselmann, H, Herrero-Beaumont, G, Kaklamanis, P, Liudmila, A, Lohmander, S, Maheu, E, Martin-Mola, E, Pavelka, K, Punzi, L, Reiter, S, Sautner, J, Verbruggen, G, Zimmerman-Gorska, I, Smolen, J

EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. by Zhang, W, Doherty, M, Leeb, B, Alekseeva, L, Arden, N, Bijlsma, J, Dincer, F, Dziedzic, K, Hauselmann, H, Kaklamanis, P, Kloppenburg, M, Lohmander, L, Maheu, E, Martin-Mola, E, Pavelka, K, Punzi, L, Reiter, S, Smolen, J, Verbruggen, G, Watt, I, Zimmermann-Gorska, I